Oxytocic Pharmaceuticals Market to worth US$ 157.6 million by 2026 End
Future Market Insights has announced the addition of the “Oxytocic Pharmaceuticals Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.
Future Market Insights has announced the addition of the “Oxytocic Pharmaceuticals Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Europe Hospital Capacity Management Solutions <strong>Market</strong><br />
The global oxy<strong>to</strong>cic pharmaceuticals revenues, however, are projected <strong>to</strong> witness an inhibited growth<br />
on the account of rising preference <strong>to</strong> alternative drugs such as magnesium sulphate and misopros<strong>to</strong>l.<br />
India’s contribution <strong>to</strong> the APEJC oxy<strong>to</strong>cic pharmaceuticals market is predicted <strong>to</strong> reach nearly 60% <strong>by</strong><br />
the end of <strong>2026</strong>.<br />
More than 22,000 thousand units of oxy<strong>to</strong>cic pharmaceuticals will be sold globally for treating labour<br />
arrest over the forecast period.<br />
Hospitals will remain the largest end-user of oxy<strong>to</strong>cic pharmaceuticals in the world, revenues from<br />
which will expand beyond 12% CAGR.<br />
A majority of medical professionals in the world will recommend intravenous administration of<br />
oxy<strong>to</strong>cic pharmaceuticals, accounting for more than two-third of global market revenues <strong>by</strong> the end of<br />
<strong>2026</strong>.<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 6
Change language